Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)

EIPICO at CPHI Milan 2026  

Octouber 8, 2026

Over the course of three days, EIPICO continued its strong participation in the CPHI Worldwide exhibition—the premier international event for pharmaceutical manufacturing and ingredients—held this year in Milan, Italy, from October 6 to 8, 2026.
 
 EIPICO was represented by a distinguished delegation of company executives, led by Dr. Ahmed Kelani, Chairman and Managing Director.
 
  EIPICO’s presence this year was marked by numerous fruitful meetings with key leaders from the global pharmaceutical and raw materials industry, business partners, and agents from around the world. Constructive discussions were held to explore promising opportunities for cooperation and strategic partnerships, as well as to strengthen the company’s raw material sourcing channels.
 
  Key topics discussed included supporting exports, expanding into new markets, and increasing product registrations in international markets.
 The delegation presented EIPICO 3 to the world following its official opening and inauguration as the first facility in Egypt and the Middle East dedicated to producing biological and biosimilar products. Additionally, the delegation introduced international markets to the EIPICO’s newest promising project: Arab Company for Active Pharmaceutical Ingredients (ARAB API), which will house the region's first multi-purpose facility for producing active pharmaceutical ingredients (APIs) and intermediates.
 
 High-level meetings were also held with Dr. Hisham Stait, Chairman of the The Egyptian Authority for Unified Procurement "UPA", and Dr. Tarek El-Hoby, Chairman of the Egyptian National Food Safety Authority (NFSA). We successfully achieved our predefined goals by solidifying the company's position on the global pharmaceutical stage and opening new horizons for collaboration with partners and clients worldwide.
 
 
A special note of gratitude goes to Dr. Olfat Ghorab, Chairman of ACDIMA, for honoring our booth with her visit and supporting our efforts—a gesture that is deeply appreciated.
 
Sincere thanks and appreciation go to the EIPICO team who participated in the exhibition, exemplifying a highly honorable image of the company through their professionalism, commitment, and positive energy throughout the event.
 
 
We also extend our heartfelt thanks to all colleagues working tirelessly behind the scenes—coordinating, preparing, and following up to ensure the success of this participation. Though some efforts may remain unseen, they were undoubtedly an essential part of this accomplishment.





















WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

[email protected]

Back to top
Powered by EIPICO Team
     Visitors Count : 2366178